MedWatch

The Medwatch panel: Is Denmark falling behind as an entrepreneurial country?

Is the lack of risk capital and the high tax burden in Denmark undercutting innovation in the country’s biotech industry – or is it just a myth? This week’s Medwatch panel of three top-execs and one politician offer their opinions on the matter.

According to a survey published at the world’s largest biotech convention in Boston earlier this year, the US is the only country more favorable than Denmark for setting up a biotech cluster.

The extensive analysis ranked 50 countries based on a range of parameters, such as available capital, protection of intellectual property rights, education and work force, political climate and political stability and the role biotech played for the overall economy.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier